Merit Medical Systems Inc
$ 89.04
1.54%
07 Aug - close price
- Market Cap 5,316,616,000 USD
- Current Price $ 89.04
- High / Low $ 89.27 / 87.47
- Stock P/E 36.20
- Book Value 27.27
- EPS 2.46
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.05 %
- ROE 0.09 %
- 52 Week High 94.75
- 52 Week Low 59.74
About
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, intensive care, and endoscopy. The company is headquartered in South Jordan, Utah.
Analyst Target Price
$99.82
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-07-30 | 2026-04-30 | 2026-02-24 | 2025-10-30 | 2025-07-30 | 2025-04-24 | 2025-02-25 | 2024-10-30 | 2024-08-01 | 2024-04-30 | 2024-02-28 | 2023-10-26 |
| Reported EPS | 1.09 | 0.94 | 1.04 | 0.92 | 1.01 | 0.86 | 0.93 | 0.86 | 0.92 | 0.77 | 0.81 | 0.75 |
| Estimated EPS | 0.85 | 0.83 | 0.9498 | 0.83 | 0.85 | 0.75 | 0.83 | 0.8 | 0.87 | 0.72 | 0.77 | 0.65 |
| Surprise | 0.24 | 0.11 | 0.0902 | 0.09 | 0.16 | 0.11 | 0.1 | 0.06 | 0.05 | 0.05 | 0.04 | 0.1 |
| Surprise Percentage | 28.2353% | 13.253% | 9.4967% | 10.8434% | 18.8235% | 14.6667% | 12.0482% | 7.5% | 5.7471% | 6.9444% | 5.1948% | 15.3846% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: MMSI
2026-08-07 10:41:37
Merit Medical Systems' Chief Operating Officer, Neil Peterson, recently sold 68% of his holdings, netting US$1.8m. This significant sale, along with other insider selling activities totaling US$7.3m over the last year, raises some concerns despite the company's profitability and strong insider ownership. While high insider ownership is positive, the consistent selling suggests caution.
2026-08-06 18:41:37
Merit Medical Systems (MMSI) COO Neil Peterson sold 21,449 shares of the company for approximately $1.82 million, reducing his direct ownership to 25,551 shares. This sale is part of a broader insider selling trend, with 9 insider sells versus 5 buys over the past year. Despite this, the company is considered "Fairly Valued" by GuruFocus with a GF Value of $95.76, and all 6 tracked institutional gurus have increased their holdings, suggesting a divergence in sentiment between insiders and institutional investors.
2026-08-06 00:06:00
Merit Medical Systems, Inc. announced its participation in two investor conferences in August 2026. Management will hold fireside chats at the Canaccord Genuity 46th Annual Growth Conference and the Bank of America SMID Cap Conference. Live audio webcasts and replays will be available on the company's investor relations website.
2026-08-05 18:40:41
Merit Medical Systems Inc. COO Neil W. Peterson sold 21,449 shares of common stock at $85.00 per share on August 4, 2026. Following this transaction, Peterson directly holds 25,551 common shares and non-qualified stock options for an additional 38,576 shares at various exercise prices and vesting schedules. The sale generated $1.82 million and was reported via a Form 4 filing.
2026-08-05 15:41:36
Merit Medical Systems, Inc. (NASDAQ: MMSI) announced its participation in two investor conferences in August 2026. Management will host a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on August 11 and at the Bank of America SMID Cap Conference on August 12. Live audio webcasts and 90-day replays will be available on the company's investor relations website.
2026-08-04 20:10:43
A Form 144 filing indicates a proposed sale of up to 21,449 shares of Merit Medical Systems Inc. (MMSI) common stock by an affiliate. The shares, consisting of Performance Shares and Restricted Stock granted in 2025 and 2026, are expected to be sold on the NASDAQ on or after August 4, 2026, through Morgan Stanley Smith Barney LLC Executive Financial Services. This notice provides advance disclosure of potential market sales.
